← Back to Search

Cardiac Monitoring Device

µCor for Heart Failure (BMADHF Trial)

N/A
Waitlist Available
Research Sponsored by Zoll Medical Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6 months
Awards & highlights

BMADHF Trial Summary

This trial is testing a new device to help people with heart failure. For 90 days, participants will wear the device and have their symptoms checked at regular intervals. They will also keep a diary of their symptoms and any heart-failure related events. After the trial, they will be contacted to see how they are doing.

BMADHF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation of µCor measured thoracic fluid index to heart failure related clinical events
Secondary outcome measures
Correlation of cardiac rhythm µCor measurements to heart failure related clinical events
Correlation of hospitalizations µCor measurements to heart failure related clinical events
Correlation of medication changes µCor measurements to heart failure related clinical events
+4 more

BMADHF Trial Design

1Treatment groups
Experimental Treatment
Group I: µCor wearersExperimental Treatment1 Intervention
Wear the µCor device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
µCor
2018
N/A
~60

Find a Location

Who is running the clinical trial?

Zoll Medical CorporationLead Sponsor
41 Previous Clinical Trials
21,571 Total Patients Enrolled
13 Trials studying Heart Failure
3,267 Patients Enrolled for Heart Failure
Steven J. Szymkiewicz, MDStudy DirectorZoll Medical Corporation
1 Previous Clinical Trials
705 Total Patients Enrolled
1 Trials studying Heart Failure
705 Patients Enrolled for Heart Failure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still availability to join this experiment?

"As reported on clinicaltrials.gov, this study is no longer actively seeking participants; the trial was initially posted on June 25th 2018 and its last update occurred on May 2nd 2022. Fortunately, there are still 701 other trials that require enrolment at present."

Answered by AI

How many localities are offering this trial procedure?

"Patients are being welcomed at CardioVogage in McKinney, Texas, JPS Health Network in Fort Worth, West virginia and the Texas Institute of Cardiology in Huntington, Illinois as well as 22 additional sites."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Benefits of µCor in Ambulatory Decompensated Heart Failure
2018. "Benefits of µCor in Ambulatory Decompensated Heart Failure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03476187.
~73 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top